Company: REVB
Filing Date: 2025-06-09
Form Type: DEF 14A
Source: 0000950170-25-083815
Chunk: 65

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-06-09
Form: DEF 14A
Chunk 65
---
    All other 
 compensation 
       ($)(2) |     |        Total 
 compensation 
          ($) |
| James Rolke             |     | 2024 |     | 561,000 |     | 237,500 |     | —           |     | —            |     | —              |     | —         |     |       14,726 |     |      813,226 |
| CEO                     |     | 2023 |     | 475,000 |     | 160,000 |     | —           |     | -            |     | —              |     | —         |     |       14,250 |     |      649,250 |
| Chester S. Zygmont, III |     | 2024 |     | 405,000 |     | 142,579 |     | —           |     | —            |     | —              |     | —         |     |       16,427 |     |      564,006 |
| CFO                     |     | 2023 |     | 356,488 |     | 112,000 |     | —           |     | -            |     | —              |     | —         |     |       10,693 |     |      479,141 |

____________ (1) The amounts reflected in the column entitled “Bonus” reflect the cash amount of bonus earned by each of the officers in consideration for their fiscal 2024 and 2023 performance, respectively, but paid to such officers during fiscal 2025 and 2024, respectively. (2) Amounts shown in this column represent the aggregate grant date fair value of stock options granted during the year. The assumptions used in calculating the fair value of the stock options can be found under Note 11 to the audited Financial Statements appearing in our Annual Report on Form 10-K for the year ended December 31, 2024. These amounts reflect the grant date fair value for these stock options and do not necessarily correspond to the actual value that will be realized by the named executive officers. (3) Unless otherwise indicated, the amounts reported in this column represent the Company’s matching contribution to the named executive officers Simple IRA plan account paid by the Company.

<div align='center'>49</div>

OUTSTANDING EQUITY AWARDS AT FISCAL YEAR END The following table provides information regarding the 2021 Equity Incentive Plan awards and the 2020 Equity Incentive